{"entity":{"type":"insider","cik":"0001644164","url":"/insider/0001644164","json_url":"/insider/0001644164.json","name":"Nestle Health Science US Holdings, Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2020-04-24","last":"2020-05-21","span_basis":"filed_date"},"name_variants":[{"name":"Nestle Health Science US Holdings, Inc.","source":"filing","n_filings":2,"first_seen":"2020-04-24","last_seen":"2020-05-21"}],"transactions":[{"id":3276231,"accession":"0000899243-20-013883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-013883","line_url":"/filing/0000899243-20-013883#line-1","is_derivative":false,"issuer_cik":"0000792990","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0000792990","owner_cik":null,"owner_name":"Societe des Produits Nestle S.A.; NESTLE SA; Nestle Health Science US Holdings, Inc.; NIMCO US, Inc.; Nestle US Holdco, Inc.","owner_display_name":"Societe des Produits Nestle S.A.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1936842.0,"shares_display":"1,936,842","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":9199999.5,"total_display":"9,199,999.50","total_whole":"9,200,000","shares_owned_after":4305541.0,"shares_owned_after_display":"4,305,541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-21","scope":"insider"},{"id":3074469,"accession":"0000899243-20-011292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-011292","line_url":"/filing/0000899243-20-011292#line-2","is_derivative":false,"issuer_cik":"0000792990","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0000792990","owner_cik":null,"owner_name":"Nestle Health Science US Holdings, Inc.; NIMCO US, Inc.; NESTLE SA","owner_display_name":"Nestle Health Science US Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3237529.0,"shares_display":"3,237,529","price_per_share":30.27,"price_display":"30.27","price_state":"stated","total_value":98000002.83,"total_display":"98,000,002.83","total_whole":"98,000,003","shares_owned_after":11727113.0,"shares_owned_after_display":"11,727,113","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-28","filed_date":"2020-04-24","scope":"insider"},{"id":3074463,"accession":"0000899243-20-011292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-011292","line_url":"/filing/0000899243-20-011292#line-1","is_derivative":false,"issuer_cik":"0000792990","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0000792990","owner_cik":null,"owner_name":"Nestle Health Science US Holdings, Inc.; NIMCO US, Inc.; NESTLE SA","owner_display_name":"Nestle Health Science US Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":937500.0,"shares_display":"937,500","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":30000000.0,"total_display":"30,000,000.00","total_whole":"30,000,000","shares_owned_after":8489584.0,"shares_owned_after_display":"8,489,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2020-04-24","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001633070","name":"Axcella Health Inc.","url":"/issuer/0001633070","role":"Ten percent owner","n_filings":1,"first_seen":"2020-05-21","last_seen":"2020-05-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001631650","name":"Aimmune Therapeutics, Inc.","url":"/issuer/0001631650","role":"Ten percent owner","n_filings":1,"first_seen":"2020-04-24","last_seen":"2020-04-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001644164","retrieved_at":"2026-08-22T05:25:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}